New therapy drug launched for Chronic Kidney Disease patients with Type 2 Diabetes
MANILA, Philippines — German pharmaceutics company Bayer is launching nationwide a new innovative therapy drug Finerenone (Firialta) for the benefit of patients with Chronic Kidney Disease (CKD) that also have Type 2 Diabetes (T2D). T2D, along with …